News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Oregon Bio on COVID-19: 11 Tips to manage and mitigate small business impact

During this time of significant disruption to local bio businesses, firms and organizations, as well as the potential global effects that are sure to be felt at all levels, Oregon Bio has researched some helpful resources and asked a few experts about short-term support to help small businesses mitigate and manage through this worldwide pandemic.

March 24, 2020 |

What Governor Brown’s “Stay Home, Stay Healthy” order means for bioscience in Oregon

On March 23, Governor Brown issued Executive Order No. 20-12 expanding on her previous restrictions on business operations. We are thankful for the work Gov. Brown and the legislature are doing to prevent the spread of the coronavirus.  If Gov. Brown decides it is necessary to expand upon this Executive Order, we will continue to advocate for the adoption of the federal DHS/CISA list of Essential Businesses as part of any additional “Stay Home/Shelter in Place” order.  The current order lists additional […]

Voice of Academia: The Making of a Scientist, Part 2

In the last issue, we introduced you to Carlos Crespo, Dr.PH, a doctor of Public Health with Portland State University. He’s using his own cultural background to build a new approach to cultivating diversity in new scientists/researchers.

Dr. Crespo and colleagues spearheaded a 10-year NIH grant to expose emerging college students to the fields of biomedical research. His grant application arrived at NIH (National Institutes of Health) at a time when NIH wanted to examine how to […]

February 28, 2020 |

Beaverton’s HTC completes Inventor Space Feasibility Study: Part 2

The Health Technology Collaborative recently completed its charge from Business Oregon, via a grant in the High Impact Opportunity Program (HIOP).  The results of the feasibility study dovetail well with the mission of the Health Technology Collaborative, which is to accelerate the growth of health technology in Oregon by providing innovators with sector-specific prototyping technology and access to a community of experts.

The $148,000 HIOP support was granted to the HTC in January, 2019, to examine the feasibility of […]

Voice of Academia with PSU’s Dr. Carlos Crespo: The Beginning of a Scientist

We recently talked with Carlos Crespo, Dr.PH, who holds a doctorate in Public Health and works at Portland State University (PSU) as Vice Provost of Undergraduate Training in Biomedical Research, about how his life work is about creating scientists. He is our second profile on this intermittent series, Voice of Academia.

About half a decade ago, Dr. Crespo honed his observations about how industry clusters form and thrive, especially when the cluster was diverse in industry and workforce. He observed that […]

February 18, 2020 |

The BREX Card: The Corporate Credit Card for Life Sciences

Think you’re fully up to speed on the many discounts and program offerings through BIO’s Business Solutions? Now our sector has a tailor credit solution, the BREX Credit Card.

BREX, the corporate credit card for the Life Sciences, is designed to empower its life sciences customers to spend less time on end-of-month closes and more time focusing on what you do best: creating and supporting life-changing R&D.

February 3, 2020 |

Calling all Bio-Entrepreneurs

The Biotechnology Innovation Organization (BIO) is teaming up to present the I-Corps Bio-Entrepreneurship Workshop in San Diego June 7-10, during BIO 2020, the industry’s premier annual international event. Diverse partners are collaborating to provide this unique and intensive 3-day session, including experts from workshop partners including BIO, United Negro College Fund, National Science Foundation, Ernest E. Just Institute for the Life Sciences, AUTM, VentureWell, University of New Hampshire I-Corps, CSU I-Corps and MIT I-Corps.

“This workshop comes highly recommended […]

Millendo Therapeutics is considering a corporate reorganization after its lead drug, an investigational treatment for a rare genetic condition characterized by unrelenting hunger, did not perform bett [...]

Join the club, Deerfield. The investment management firm raised $840 million for its second healthcare-focused fund, joining Arch Venture Partners, Flagship Pioneering and venBio Partners, all of whic [...]

President Trump on Monday claimed that an inspector general report finding "severe" shortages of supplies at hospitals to fight the novel coronavirus is "just wrong."Trump did not [...]

Louisiana Gov. John Bel Edwards (D) said Monday that the state is no longer likely to run out of hospital beds before the end of the week, with officials believing the rate of new coronavirus cases is [...]

President Trump announced Monday that he has reached an "amicable" agreement with the company 3M to produce masks for health care workers, after Trump bashed the company last week. The compa [...]

GlaxoSmithKline has agreed to invest $250 million in infectious disease specialist Vir Biotechnology to launch a COVID-19 R&D alliance that the companies say could advance two experimental therapi [...]

Gilead launched a four-year collaboration with the microbiome-focused Second Genome, to develop new biomarkers that can track clinical responses to its drugs aimed at inflammation, fibrosis and more. [...]

British Prime Minister Boris Johnson has been moved to intensive care after being hospitalized Sunday with coronavirus, the prime minister's office said Monday."Over the course of this after [...]